enzastaurin has been researched along with cilengitide in 1 studies
| Studies (enzastaurin) | Trials (enzastaurin) | Recent Studies (post-2010) (enzastaurin) | Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) |
|---|---|---|---|---|---|
| 188 | 52 | 99 | 194 | 29 | 133 |
| Protein | Taxonomy | enzastaurin (IC50) | cilengitide (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 0.3087 | |
| Integrin beta-1 | Homo sapiens (human) | 1.0131 | |
| Integrin alpha-V | Homo sapiens (human) | 0.514 | |
| Integrin alpha-IIb | Homo sapiens (human) | 2.399 | |
| Integrin alpha-5 | Homo sapiens (human) | 0.9006 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Integrin beta-5 | Homo sapiens (human) | 0.4791 | |
| Integrin beta-6 | Homo sapiens (human) | 4.042 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0005 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Ma, W; Wang, J; Yan, C; Yang, Y | 1 |
1 review(s) available for enzastaurin and cilengitide
| Article | Year |
|---|---|
Molecular biomarker-guided anti-angiogenic targeted therapy for malignant glioma.
Topics: Angiogenesis Inhibitors; Bevacizumab; Biomarkers, Tumor; Brain Neoplasms; Glioma; Humans; Indoles; Molecular Targeted Therapy; Prognosis; Snake Venoms | 2019 |